However, a human disease called osteoglophonic dysplasia caused by activating mutations in FGFR1 is often associated with hypophosphatemia due to increased FGF23 levels (60), which also suggests the regulation of FGF23 production by FGFR signaling. The gene discussed is FGF23; the disease is hypophosphatemia.